July 8 Financial Quick Takes: IGM raises mega-round; plus Mirium, Fulcrum set IPO ranges and more

IGM raises $102M C round

IGM Biosciences Inc. (Mountain View, Calif.) raised $102 million in a series C round that included new investors Redmile Group, Janus Henderson Investors, Vivo Capital and an undisclosed U.S.-based healthcare investor, as well as existing investor Haldor Topsøe Holding A/S. Next year, the company expects to start clinical testing of lead therapy IGM 2323, a bispecific CD20xCD3 IgM antibody, to treat non-Hodgkin lymphoma and chronic lymphocytic leukemia. ...